Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.

Abstract

The results suggest that use of the exchange led to a significant reduction in hepatitis B and hepatitis C in the county and may have also prevented a substantial proportion of human immunodeficiency virus infections in injection drug users.